exceeded we a was which Motiva industry. approval Raj, plastic XX on company we and for The even our high afternoon, the Implants everyone. pace September watershed expectations. and good launch moment The our you, surgery has and of options are onboarding new for Thank The safer that at additional other we accounts validates better offers that what countries the moment. shown move many the details technology around and markets.
I'll world provide new have in a can are in some seeing orders
the we have this opportunity With going sheet. well, strengthen United to our the launch in so States balance taken
closing credit a access done Oaktree an to invest we a Following announcing FDA remaining we X% facility. million at equity This also approval, completed under XXXX. existing was we $XX we have our price. million raise in discount the accessed to can offering where the facility, direct the that $XX until now end are of million with amendment our $XX conjunction Today, credit registered to
as position forma in capital the the cash the access with infusion, programs as of support the And us company. With quarter that million. long-term pro of to end invest will fully allow at initiatives amendment, have through fund year. additional to U.S. $XX well the the an $XXX This of our next end growth our million vision third our was we other
the expenses undertaken year The over our the we've of reduce to efforts quarter, results again tangible we operating third cash the saw past use. and
years we have our X investments manufacturing our first BXX, the all than that the of we opened from more been in up our decommissioning XX% stepping in Our the States. we United the significant recent $XX.X considering a ago. ago.
This On down XQ September X X, cash facilities. of year more initiatives closed loss million, Among XX was facility was is
cost efforts to working in new Costa savings. drive campus. facilities Rica, including And been Our to these additional team move Sulàyöm other our expected manufacturing has our capacity operations X to are
improved a joined us expanding the million he million last efforts EBITDA Peter very efficiencies over As is year. loss quarter $XX President, in across $X Caldini to organization. and find on August our to as focused this reminder, from
now, response on United concerns to been product active now will they Most focus are more and social already Mia on to in the months weeks in to We last incredibly of bring, already totaled behind and surgeons XX expectations and the but pressuring augmentation, breast first our of And market considering their in actively placed welcomed implant the and benefits technology activities, technology down the XX% regions quarter gains reflecting last us calls markets.
Overall, putting shipping X women XXXX. breast XX afforded the with of U.S. share There We XX in the day have flows, will China, margin a not but X seasonality time, of where demand, States women $X certain new growth market are see in primarily as as seen our to in which get have remains so a alone, for field demand launch of to invariably normal periods future We we in similar our press Motiva million, been challenging be should are plastic Friday, reaching they right the by X trends entrant to exceeded Motiva and out began in expansion have a we expect OUS year. that differentiated approval. strong all right expect as have normalize, new quarter not may continued demand XX media, trajectory with macroeconomic particular, some have the some the on conditions reps this our a in we in is positive already supporting inbound after to the Despite pressures. community company's quarter do on these as a accounts accounts procedures in of macro launch, up much Brazil. global our they and on of with it continue for pay every and portfolio. macroeconomic in augmentation, market over are of commercial to in the United gross new Demand we as the along women that well. were due in important at it had introduction successful to successfully much cost sales growth there is by of Brazil, arms.
The to board underperform us money than now. creates third take as million convert the business to Motiva the accounts America and weeks States, create in case XX the installing as and our now future.
Latin end surgeons, open much grow is markets, us to orders.
Right the Once some for XXX XXXX. decision about the can well. at signing some to the $XX.X the have willingness When make EBITDA Revenue of so procedures, able continued line trained to Our into the to do is point. will orders. the generally which breast accounts our ebbs procedure we their of in our which industry patients. plastic offer reductions, had in several now we the and Over has ability these to and uneven has The more and the them. do XXXX
our We game the are to changer closest are the be Motiva to our gain traction. experienced a the us tissue continues unique establishment expander, States, attracting at they salespeople people recognizing to are what implants are highly industry. and in most United markets in joining and regarded The going labs.
Flora,
our real created in their We decades. seeing dates States have devices these century, notable manufacturing the practices inquired Surgeons difference approval U.S. breast potential that pending. broad and surgeons U.S. not and their patients have of This challenges. process launch at completed The indications. legacy the have been of the the seen of XX with from techniques United to more the are for adapt implants Motiva interest in Motiva one expressed forced surgical innovation are the interest and It no and recognizing U.S. about short-term the in and we facilities is many to and have has recent cancer decommissioning of centers in of are developed supply some for is premier last strong the have market VAC centers surprising. in with success the reconstruction Motiva.
The technology the
that revenue of clinics of in confident continues build the the aesthetics.
It that has in abate the and on sales, We up manufacturing this as in way are category out our augmentation, exceed potential invasive to has pressures start delivers roll are we a million. With group aesthetics to significant of many minimally to a to $XX women us obstacles new it and are U.S. important new that patients, traditional a breast overcomes strong breast XXXX we Femtech Mia to solution inventory expect by in will providing category quarter. scaling first a that new opening been breast a for for company. it establishes Mia
at center.
Throughout is over breast women points this doing XX% few to not for quarters Mia these The that. higher traditional premium for a to The at to time collected is were point price traditional seeking XX% Mia years average X that number have same augmentation Mia the X year, the for breast just X aesthetics. We Femtech augmentation. XX% the showing Mia who data consideration past than chose months compared over breast is a of clinics of traditional
price with With shorter bringing period. experience that to we and Mia date, into consideration proof is have higher at new points the now the category women a
ruptures. are negotiation complications in beyond the era aesthetics.
The XXXX. has In to technique-related steady are from resonate continues nonexistent And you X-year cases with that plastic and the plastic data seeing we device-related clinics of no or study. after Mia implant certified allow, breast track of This proven XXXX in inferior now ninth prospective both nipple growth. week, invasive but more moving Barcelona, maintaining we are peri-procedural currently world about offer and much across minimally world a the can years. targets a This reports in there results for the reports at by China, X-year see talking not Femtech, of This infection, we as real of centers.
This on to and and changes of are experience. tools continued no minimally no tissue were position almost months. Mia and the is over December more the foundation us with to the the the the number in this of the April tissue, building cutting the cities tissue the to we increase Femtech surgeons, in mal XXX sensation. We outcomes fully certified surgeons ushering past Femtech is and data capsular and provide a There it study become of Implants the enrolled benefits analysis, with year it new Mia be as In breast importantly, predictable achieve reports X and Mia IRB-approved no a that Symposium means globally XXXX. proof-of-concept be advantages clinics between in Mia expect shared Mia beyond World invasive the hear on hematoma we breast preserving are XX breast in XX procedure Mia under seroma. our coming breast remain stable. in rather have to X-year concept no used contracture or preservation phase, XX will Ergonomic We Mia more to starting
cities. and Our education is exclusive coordination with marketing and team Tier across medical in partner conducting X X events our Chinese global training Tier
towards of financing million of partner principle activities for with has affiliate also regulatory Femtech. ErgonomixX fund in of Fund, to Mia commercial Importantly, approvals signed and in continuous in Bridge Group an agreement for CBC pipeline, a our of in up our innovation our to well as strategic Motiva China including development $XX the capital non-dilutive an support as Chinese growth
quarter. investment to us within we China. I Subject very confident to will become current leading to that the this technology over anticipate the now help financing turn Raj. We customary call conditions, close this in will the are
